	EQUITY ALERT: Levi ' Korsinsky, LLP Reminds Shareholders of Depomed, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2017 - DEPO - ACCESS Newswire
	Depomed encourages shareholders to reject Horizon's exchange offer - FirstWord
	Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change - Fierce Pharma
	Speaker Programs: Two Recent Enforcement Actions Serve as a Reminder of the Government's Longstanding Scrutiny - Mintz
	Horizon Pharma Withdraws Bid for Depomed - WSJ
	Middle East Tapentadol Market Report Industry Insights, Share, - openPR.com
	Pharma vet Stan Bukofzer joins Depomed as CMO/CSO - Fierce Biotech
	The Numbers Are In: Bay Area’s Depomed Reveals 328 Job Cuts in WARN Notice - BioSpace